SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
20332770
Source:
http://linkedlifedata.com/resource/pubmed/id/20332770
Search
Subject
(
56
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0358591
,
umls-concept:C0457454
,
umls-concept:C1444662
,
umls-concept:C1457887
,
umls-concept:C1527148
pubmed:issue
7
pubmed:dateCreated
2010-7-7
pubmed:abstractText
Conflicting data exist on whether discontinuation of proton pump inhibitors (PPIs) is associated with rebound secretion of gastric acid.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20332770-20606660
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0421030
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...
,
http://linkedlifedata.com/resource/pubmed/chemical/Chromogranin A
,
http://linkedlifedata.com/resource/pubmed/chemical/Gastrins
,
http://linkedlifedata.com/resource/pubmed/chemical/Placebos
,
http://linkedlifedata.com/resource/pubmed/chemical/Proton Pump Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/pantoprazole
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1572-0241
pubmed:author
pubmed-author:BjörnssonEinarE
,
pubmed-author:LindbergGregerG
,
pubmed-author:LindströmLinaL
,
pubmed-author:NiklassonAnnaA
,
pubmed-author:SimrénMagnusM
pubmed:issnType
Electronic
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1531-7
pubmed:meshHeading
pubmed-meshheading:20332770-2-Pyridinylmethylsulfinylbenzimidazoles
,
pubmed-meshheading:20332770-Adult
,
pubmed-meshheading:20332770-Aged
,
pubmed-meshheading:20332770-Chromogranin A
,
pubmed-meshheading:20332770-Double-Blind Method
,
pubmed-meshheading:20332770-Dyspepsia
,
pubmed-meshheading:20332770-Female
,
pubmed-meshheading:20332770-Gastric Acid
,
pubmed-meshheading:20332770-Gastrins
,
pubmed-meshheading:20332770-Humans
,
pubmed-meshheading:20332770-Male
,
pubmed-meshheading:20332770-Middle Aged
,
pubmed-meshheading:20332770-Placebos
,
pubmed-meshheading:20332770-Proton Pump Inhibitors
,
pubmed-meshheading:20332770-Questionnaires
,
pubmed-meshheading:20332770-Severity of Illness Index
,
pubmed-meshheading:20332770-Statistics, Nonparametric
,
pubmed-meshheading:20332770-Sweden
pubmed:year
2010
pubmed:articleTitle
Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial.
pubmed:affiliation
Department of Internal Medicine, Section of Gastroenterology, Sahlgrenska University Hospital, Richertsgatan 18, Göteborg 412 60, Sweden. niklasson_a@hotmail.com
pubmed:publicationType
Journal Article
,
Randomized Controlled Trial